Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
121.28
-0.47 (-0.39%)
At close: Aug 29, 2025, 4:00 PM
121.28
0.00 (0.00%)
After-hours: Aug 29, 2025, 4:00 PM EDT
Axsome Therapeutics Market Cap
Axsome Therapeutics has a market cap or net worth of $6.05 billion as of August 29, 2025. Its market cap has increased by 48.61% in one year.
Market Cap
6.05B
Enterprise Value
5.98B
1-Year Change
48.61%
Ranking
Category
Stock Price
$121.28
Market Cap Chart
Since November 19, 2015, Axsome Therapeutics's market cap has increased from $154.90M to $6.05B, an increase of 3,807.39%. That is a compound annual growth rate of 45.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 6.08B | 48.17% |
| Dec 31, 2024 | 4.10B | 8.87% |
| Dec 29, 2023 | 3.77B | 12.44% |
| Dec 30, 2022 | 3.35B | 135.22% |
| Dec 31, 2021 | 1.42B | -53.19% |
| Dec 31, 2020 | 3.04B | -14.70% |
| Dec 31, 2019 | 3.57B | 4,141.14% |
| Dec 31, 2018 | 84.10M | -36.58% |
| Dec 29, 2017 | 132.60M | 2.55% |
| Dec 30, 2016 | 129.30M | -21.30% |
| Dec 31, 2015 | 164.30M | 6.07% |
| Nov 19, 2015 | 154.90M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.76B |
| Johnson & Johnson | 425.05B |
| AbbVie | 368.08B |
| UnitedHealth Group | 272.09B |
| AstraZeneca | 248.21B |
| Novartis AG | 243.97B |
| Novo Nordisk | 243.46B |
| Abbott Laboratories | 229.03B |